Dr. Madison Kelly

Technical Specialist of Precision Medicine, Labcorp Oncology

Dr. Madison Kelly is a Technical Specialist of Precision Medicine at Labcorp Oncology, where she supports customers' efforts to accelerate the adoption of NGS assays in clinical diagnostic laboratories worldwide. Joining the PGDx (now a part of Labcorp) team as a Field Application Specialist in 2021, Dr. Kelly contributed to training, installation, and clinical implementation of PGDx NGS diagnostic assays in at least 15 laboratories. Having received her Doctor of Philosophy from Melbourne University and the Peter MacCallum Cancer Centre, along with post-doctoral studies at Weill Cornell Medicine, Dr. Kelly has made significant contributions to diverse cancer research. This includes investigating epigenetic perturbations in normal and malignant hematopoiesis and exploring 3D chromatin topology in B cells, resulting in publication of 10 peer-reviewed articles and numerous presentations at national and international conferences. Dr. Kelly is passionate about leveraging her technical expertise and academic background to advance NGS accessibility to make a meaningful impact in the field of Precision Medicine.